A new scientific study takes a different approach in treating cancer by targeting genetic mutations instead of where the tumor starts in the body.
Study using thymidylate synthase as a predictive and prospective biomarker; Report on a trial with a drug that targets the folate receptor
Clinical trials in patients planned
